Teva Pharma shares jump 17% on pending agreement over opioid litigation
July 26, 2022 at 17:54 PM EDT
Teva ADRs jump 17% to $8.31 late Tuesday after the company reaches agreement in principle to resolve the majority of its opioid-related litigation.
